Medartis Holding AG (SW:MED) — Market Cap & Net Worth
Market Cap & Net Worth: Medartis Holding AG (MED)
Medartis Holding AG (SW:MED) has a market capitalization of $1.17 Billion (CHF929.30 Million) as of May 2, 2026. Listed on the SW stock exchange, this Switzerland-based company holds position #8414 globally and #112 in its home market, demonstrating a -2.78% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medartis Holding AG's stock price CHF76.90 by its total outstanding shares 12432612 (12.43 Million). Review MED liabilities breakdown to assess the company's total debt and financial obligations.
Medartis Holding AG Market Cap History: 2018 to 2026
Medartis Holding AG's market capitalization history from 2018 to 2026. Data shows growth from $870.79 Million to $1.21 Billion (2.70% CAGR).
Medartis Holding AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medartis Holding AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.96x
Medartis Holding AG's market cap is 3.96 times its annual revenue
Latest Price to Earnings (P/E) Ratio
252.17x
Medartis Holding AG's market cap is 252.17 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $870.79 Million | $121.32 Million | $4.20 Million | 7.18x | 207.24x |
| 2019 | $686.88 Million | $130.14 Million | $2.15 Million | 5.28x | 320.00x |
| 2020 | $730.90 Million | $127.65 Million | -$943.57K | 5.73x | N/A |
| 2021 | $2.05 Billion | $159.88 Million | $6.84 Million | 12.80x | 299.29x |
| 2022 | $1.29 Billion | $182.82 Million | -$5.78 Million | 7.05x | N/A |
| 2023 | $1.32 Billion | $212.01 Million | $619.00K | 6.23x | 2133.00x |
| 2024 | $889.65 Million | $224.83 Million | $3.53 Million | 3.96x | 252.17x |
Competitor Companies of MED by Market Capitalization
Companies near Medartis Holding AG in the global market cap rankings as of May 2, 2026.
Key companies related to Medartis Holding AG by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #140 globally with a market cap of $157.87 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #196 globally with a market cap of $120.60 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #234 globally with a market cap of $103.80 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #140 | Abbott Laboratories | NYSE:ABT | $157.87 Billion | $90.79 |
| #196 | Stryker Corporation | NYSE:SYK | $120.60 Billion | $315.13 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #234 | Medtronic PLC | NYSE:MDT | $103.80 Billion | $80.97 |
Medartis Holding AG Historical Marketcap From 2018 to 2026
Between 2018 and today, Medartis Holding AG's market cap moved from $870.79 Million to $ 1.21 Billion, with a yearly change of 2.70%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CHF1.21 Billion | -12.81% |
| 2025 | CHF1.39 Billion | +55.83% |
| 2024 | CHF889.65 Million | -32.62% |
| 2023 | CHF1.32 Billion | +2.44% |
| 2022 | CHF1.29 Billion | -37.02% |
| 2021 | CHF2.05 Billion | +180.00% |
| 2020 | CHF730.90 Million | +6.41% |
| 2019 | CHF686.88 Million | -21.12% |
| 2018 | CHF870.79 Million | -- |
End of Day Market Cap According to Different Sources
On May 1st, 2026 the market cap of Medartis Holding AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.17 Billion USD |
| MoneyControl | $1.17 Billion USD |
| MarketWatch | $1.17 Billion USD |
| marketcap.company | $1.17 Billion USD |
| Reuters | $1.17 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Medartis Holding AG
Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides osteosynthesis products for the hand, wrist, forearm, elbow, shoulder, and fo… Read more